Wide variation in the multiplicity of HIV-1 infection among injection drug users

Journal of Virology

Volumn 84, Issue 12, 2010, Pages 6241-6247

  Bar, Katharine J ^a   Li, Hui ^a   Chamberland, Annie ^b   Tremblay, Cecile ^c   Routy, Jean Pierre ^d   Grayson, Truman ^a   Sun, Chuanxi ^a   Wang, Shuyi ^a   Learn, Gerald H ^a   Morgan, Charity J ^a   Schumacher, Joseph E ^a   Haynes, Barton F ^e   Keele, Brandon F ^f   Hahn, Beatrice H ^a   Shaw, George M ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

^d MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^e DUKE UNIVERSITY MEDICAL CENTER   (United States)

^f SAIC FREDERICK INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; DRUG USE; FEMALE; GENE AMPLIFICATION; GENE SEQUENCE; GENETIC VARIABILITY; HETEROSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INFECTION RISK; INJECTION DRUG USE; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENETIC TREE; PRIORITY JOURNAL; VIRUS TRANSMISSION;

ADOLESCENT; ADULT; BASE SEQUENCE; COHORT STUDIES; DRUG USERS; FEMALE; GENETIC VARIATION; GENOME, VIRAL; HIV ENVELOPE PROTEIN GP160; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; RUSSIA; SEQUENCE ANALYSIS, DNA; YOUNG ADULT;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 77952678708     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.00077-10     Document Type: Article

References (49)

1. Abrahams, M.-R., J. A. Anderson, E. E. Giorgi, C. Seoighe, K. Mlisana, L.-H. Ping, G. S. Athreya, F. K. Treurnicht, B. F. Keele, N. Wood, J. F. Salazar- Gonzalez, T. Bhattacharya, H. Chu, I. Hoffman, S. Galvin, C. Mapanje, P. Kazembe, R. Thebus, S. Fiscus, W. Hide, M. S. Cohen, S. A. Karim, B. F. Haynes, G. M. Shaw, B. H. Hahn, B. T. Korber, R. Swanstrom, and C. Williamson. 2009. Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-Poisson distribution of transmitted variants. J. Virol. 83:3556-3567.
2. Aceijas, C., G. V. Stimson, M. Hickman, and T. Rhodes. 2004. Global overview of injecting drug use and HIV infection among injecting drug users. AIDS 18:2295-2303. (Pubitemid 39620222)
3. Baggaley, R. F., M. C. Boily, R. G. White, and M. Alary. 2006. Risk of HIV-1 transmission for parenteral exposure and blood transfusion: a systematic review and meta-analysis. AIDS 20:805-812.
4. Brogly, S. B., J. Bruneau, J. Vincelette, F. Lamothe, and E. L. Franco. 2000. Risk behaviour change and HIV infection among injection drug users in Montreal. AIDS 14:2575-2582.
5. Bruneau, J., F. Lamothe, E. Franco, N. Lachance, M. Desy, J. Soto, and J. Vincelette. 1997. High rates of HIV infection among injection drug users participating in needle exchange programs in Montreal: results of a cohort study. Am. J. Epidemiol. 146:994-1002.
6. Derdeyn, C. A., J. M. Decker, F. Bibollet-Ruche, J. L. Mokili, M. Muldoon, S. A. Denham, M. L. Heil, F. Kasolo, R. Musonda, B. H. Hahn, G. M. Shaw, B. T. Korber, S. Allen, and E. Hunter. 2004. Envelope-constrained neutralization-sensitive HIV-1 after heterosexual transmission. Science 303:2019-2022. (Pubitemid 38393277)
7. Dolin, R. 2009. HIV vaccine trial results - an opening for further research. N. Engl. J. Med. 361:2279-2280.
8. Fiebig, E. W., D. J. Wright, B. D. Rawal, P. E. Garrett, R. T. Schumacher, L. Peddada, C. Heldebrant, R. Smith, A. Conrad, S. H. Kleinman, and M. P. Busch. 2003. Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection. AIDS 17:1871-1879.
9. Fischer, B., J. Rehm, S. Brissette, S. Brochu, J. Bruneau, N. El-Guebaly, L. Noel, M. Tyndall, C. Wild, P. Mun, and D. Baliunas. 2005. Illicit opioid use in Canada: comparing social, health, and drug use characteristics of untreated users in five cities (OPICAN study). J. Urban Health 82:250-266. (Pubitemid 41214941)
10. Flynn, N. M., D. N. Forthal, C. D. Harro, F. N. Judson, K. H. Mayer, and M. F. Para. 2005. Placebo-controlled phase 3 trial of a recombinant glycoprotein 120 vaccine to prevent HIV-1 infection. J. Infect. Dis. 191:654-665.
11. Gottlieb, G. S., L. Heath, D. C. Nickle, K. G. Wong, S. E. Leach, B. Jacobs, S. Gezahegne, A. B. van 't Wout, L. P. Jacobson, J. B. Margolick, and J. I. Mullins. 2008. HIV-1 variation before seroconversion in men who have sex with men: analysis of acute/early HIV infection in the multicenter AIDS cohort study. J. Infect. Dis. 197:1011-1015.
12. Greenier, J. L., C. J. Miller, D. Lü, P. J. Dailey, F. X. Lu, K. J. Kunstman, S. M. Wolinsky, and M. L. Marthas. 2001. Route of simian immunodeficiency virus inoculation determines the complexity but not the identity of viral variant populations that infect rhesus macaques. J. Virol. 75:3753-3765.
13. Haaland, R. E., P. A. Hawkins, J. Salazar-Gonzalez, A. Johnson, A. Tichacek, E. Karita, O. Manigart, J. Mulenga, B. F. Keele, G. M. Shaw, B. H. Hahn, S. A. Allen, C. A. Derdeyn, and E. Hunter. 2009. Inflammatory genital infections mitigate a severe genetic bottleneck in heterosexual transmission of subtype A and C HIV-1. PLoS Pathog. 5:e1000274.
14. Haase, A. T. 2005. Perils at mucosal front lines for HIV and SIV and their hosts. Nat. Rev. Immunol. 5:783-792.
15. Hladik, F., and M. J. McElrath. 2008. Setting the stage: host invasion by HIV. Nat. Rev. Immunol. 8:447-457.
16. Hladik, F., P. Sakchalathorn, L. Ballweber, G. Lentz, M. Fialkow, D. Eschenbach, and M. J. McElrath. 2007. Initial events in establishing vaginal entry and infection by human immunodeficiency virus type-1. Immunity 26:257-270. (Pubitemid 46329434)
17. Kearney, M., F. Maldarelli, W. Shao, J. B. Margolick, E. S. Daar, J. W. Mellors, V. Rao, J. M. Coffin, and S. Palmer. 2009. Human immunodeficiency virus type 1 population genetics and adaptation in newly infected individuals. J. Virol. 83:2715-2727.
18. Keele, B. F., E. E. Giorgi, J. F. Salazar-Gonzalez, J. M. Decker, K. T. Pham, M. G. Salazar, C. Sun, T. Grayson, S. Wang, H. Li, X. Wei, C. Jiang, J. L. Kirchherr, F. Gao, J. A. Anderson, L. H. Ping, R. Swanstrom, G. D. Tomaras, W. A. Blattner, P. A. Goepfert, J. M. Kilby, M. S. Saag, E. L. Delwart, M. P. Busch, M. S. Cohen, D. C. Montefiori, B. F. Haynes, B. Gaschen, G. S. Athreya, H. Y. Lee, N. Wood, C. Seoighe, A. S. Perelson, T. Bhattacharya, B. T. Korber, B. H. Hahn, and G. M. Shaw. 2008. Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection. Proc. Natl. Acad. Sci. U. S. A. 105:7552-7557.
19. Keele, B. F., H. Li, G. H. Learn, P. Hraber, E. E. Giorgi, T. Grayson, C. Sun, Y. Chen, W. W. Yeh, N. L. Letvin, J. R. Mascola, G. J. Nabel, B. F. Haynes, T. Bhattacharya, A. S. Perelson, B. T. Korber, B. H. Hahn, and G. M. Shaw. 2009. Low-dose rectal inoculation of rhesus macaques by SIVsmE660 or SIVmac251 recapitulates human mucosal infection by HIV-1. J. Exp. Med. 206:1117-1134.
20. Lee, H. Y., E. E. Giorgi, B. F. Keele, B. Gaschen, G. S. Athreya, J. F. Salazar-Gonzalez, K. T. Pham, P. A. Goepfert, J. M. Kilby, M. S. Saag, E. L. Delwart, M. P. Busch, B. H. Hahn, G. M. Shaw, B. T. Korber, T. Bhattacharya, and A. S. Perelson. 2009. Modeling sequence evolution in acute HIV-1 infection. J. Theor. Biol. 261:341-360.
21. Legault, M., R. Thomas, B. Trottier, D. Rouleau, J. Baril, P. Cote, C. Tremblay, R. LeBlanc, A. Dascal, and J. Routy. 2008. Abstr. 17th Annu. Can. Conf. HIV/AIDS Res., Montreal, Quebec, Canada, abstr. 227.
22. Leri, F., J. Bruneau, and J. Stewart. 2003. Understanding polydrug use: review of heroin and cocaine co-use. Addiction 98:7-22. (Pubitemid 36044332)
23. Leri, F., J. Stewart, A. Tremblay, and J. Bruneau. 2004. Heroin and cocaine co-use in a group of injection drug users in Montreal. J. Psychiatry Neurosci. 29:40-47. (Pubitemid 38570011)
24. Li, H., K. J. Bar, S. Wang, J. M. Decker, Y. Chen, C. Sun, J. F. Salazar- Gonzalez, M. G. Salazar, G. H. Learn, C. J. Morgan, J. E. Schumacher, P. Hraber, E. E. Giorgi, T. Bhattacharya, B. T. Korber, A. S. Perelson, J. Eron, M. S. Cohen, C. B. Hicks, B. F. Haynes, M. Markowitz, B. F. Keele, B. H. Hahn, and G. M. Shaw. High multiplicity infection by HIV-1 in men who have sex with men. PLoS Pathog., in press.
25. Long, E. M., H. L. Martin, Jr., J. K. Kreiss, S. M. Rainwater, L. Lavreys, D. J. Jackson, J. Rakwar, K. Mandaliya, and J. Overbaugh. 2000. Gender differences in HIV-1 diversity at time of infection. Nat. Med. 6:71-75.
26. Lu, L., M. Jia, Y. Ma, L. Yang, Z. Chen, D. D. Ho, Y. Jiang, and L. Zhang. 2008. The changing face of HIV in China. Nature 455:609-611.
27. Ma, Z.-M., M. Stone, M. Piatak, Jr., B. Schweighardt, N. L. Haigwood, D. Montefiori, J. D. Lifson, M. P. Busch, and C. J. Miller. 2009. High specific infectivity of plasma virus from the pre-ramp-up and ramp-up stages of acute simian immunodeficiency virus infection. J. Virol. 83:3288-3297.
28. Margolis, L., and R. Shattock. 2006. Selective transmission of CCR5-utilizing HIV-1: the 'gatekeeper' problem resolved? Nat. Rev. Microbiol. 4:312-317.
29. Masharsky, A. E., E. N. Dukhovlinova, S. V. Verevochkin, O. V. Toussova, R. V. Skochilov, J. A. Anderson, I. Hoffman, M. S. Cohen, R. Swanstrom, and A. P. Kozlov. A significant transmission bottleneck among newly and recently HIV-1 infected injection drug users in St. Petersburg, Russia. J. Infect. Dis., in press.
30. Miller, C. J., Q. Li, K. Abel, E.-Y. Kim, Z.-M. Ma, S. Wietgrefe, L. La Franco-Scheuch, L. Compton, L. Duan, M. D. Shore, M. Zupancic, M. Busch, J. Carlis, S. Wolinsky, and A. T. Haase. 2005. Propagation and dissemination of infection after vaginal transmission of simian immunodeficiency virus. J. Virol. 79:9217-9227. (Pubitemid 40934833)
31. Moore, J. P., S. G. Kitchen, P. Pugach, and J. A. Zack. 2004. The CCR5 and CXCR4 coreceptors - central to understanding the transmission and pathogenesis of human immunodeficiency virus type 1 infection. AIDS Res. Hum. Retroviruses 20:111-126.
32. Munch, J., E. Rucker, L. Standker, K. Adermann, C. Goffinet, M. Schindler, S. Wildum, R. Chinnadurai, D. Rajan, A. Specht, G. Gimenez-Gallego, P. C. Sanchez, D. M. Fowler, A. Koulov, J. W. Kelly, W. Mothes, J. C. Grivel, L. Margolis, O. T. Keppler, W. G. Forssmann, and F. Kirchhoff. 2007. Semen-derived amyloid fibrils drastically enhance HIV infection. Cell 131:1059-1071. (Pubitemid 350235017)
33. Pitisuttithum, P., P. Gilbert, M. Gurwith, W. Heyward, M. Martin, F. van Griensven, D. Hu, J. W. Tappero, and K. Choopanya. 2006. Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand. J. Infect. Dis. 194:1661-1671.
34. Pope, M., and A. T. Haase. 2003. Transmission, acute HIV-1 infection and the quest for strategies to prevent infection. Nat. Med. 9:847-852.
35. Poss, M., H. L. Martin, J. K. Kreiss, L. Granville, B. Chohan, P. Nyange, K. Mandaliya, and J. Overbaugh. 1995. Diversity in virus populations from genital secretions and peripheral blood from women recently infected with human immunodeficiency virus type 1. J. Virol. 69:8118-8122.
36. Powers, K. A., C. Poole, A. E. Pettifor, and M. S. Cohen. 2008. Rethinking the heterosexual infectivity of HIV-1: a systematic review and meta-analysis. Lancet Infect. Dis. 8:553-563.
37. Rerks-Ngarm, S., P. Pitisuttithum, S. Nitayaphan, J. Kaewkungwal, J. Chiu, R. Paris, N. Premsri, C. Namwat, M. de Souza, E. Adams, M. Benenson, S. Gurunathan, J. Tartaglia, J. G. McNeil, D. P. Francis, D. Stablein, D. L. Birx, S. Chunsuttiwat, C. Khamboonruang, P. Thongcharoen, M. L. Robb, N. L. Michael, P. Kunasol, and J. H. Kim. 2009. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N. Engl. J. Med. 361:2209-2220.
38. Ritola, K., C. D. Pilcher, S. A. Fiscus, N. G. Hoffman, J. A. E. Nelson, K. M. Kitrinos, C. B. Hicks, J. J. Eron, Jr., and R. Swanstrom. 2004. Multiple V1/V2 env variants are frequently present during primary infection with human immunodeficiency virus type 1. J. Virol. 78:11208-11218.
39. Roan, N. R., and W. C. Greene. 2007. A seminal finding for understanding HIV transmission. Cell 131:1044-1046.
40. Routy, J. P., N. Machouf, M. D. Edwardes, B. G. Brenner, R. Thomas, B. Trottier, D. Rouleau, C. L. Tremblay, P. Cote, J. G. Baril, R. S. Remis, R. P. Sekaly, and M. A. Wainberg. 2004. Factors associated with a decrease in the prevalence of drug resistance in newly HIV-1 infected individuals in Montreal. AIDS 18:2305-2312.
41. Routy, J. P., P. Vanhems, D. Rouleau, C. Tsoukas, E. Lefebvre, P. Cote, R. LeBlanc, B. Conway, M. Alary, J. Bruneau, and R. P. Sekaly. 2000. Comparison of clinical features of acute HIV-1 infection in patients infected sexually or through injection drug use. The Investigators of the Quebec Primary HIV Infection Study. J. Acquir. Immune Defic. Syndr. 24:425-432.
42. Sagar, M., E. Kirkegaard, E. M. Long, C. Celum, S. Buchbinder, E. S. Daar, and J. Overbaugh. 2004. Human immunodeficiency virus type 1 (HIV-1) diversity at time of infection is not restricted to certain risk groups or specific HIV-1 subtypes. J. Virol. 78:7279-7283. (Pubitemid 38781567)
43. Salazar-Gonzalez, J. F., E. Bailes, K. T. Pham, M. G. Salazar, M. B. Guffey, B. F. Keele, C. A. Derdeyn, P. Farmer, E. Hunter, S. Allen, O. Manigart, J. Mulenga, J. A. Anderson, R. Swanstrom, B. F. Haynes, G. S. Athreya, B. T. Korber, P. M. Sharp, G. M. Shaw, and B. H. Hahn. 2008. Deciphering human immunodeficiency virus type 1 transmission and early envelope diversification by single-genome amplification and sequencing. J. Virol. 82: 3952-3970.
44. Salazar-Gonzalez, J. F., M. G. Salazar, B. F. Keele, G. H. Learn, E. E. Giorgi, H. Li, J. M. Decker, S. Wang, J. Baalwa, M. H. Kraus, N. F. Parrish, K. S. Shaw, M. B. Guffey, K. J. Bar, K. L. Davis, C. Ochsenbauer-Jambor, J. C. Kappes, M. S. Saag, M. S. Cohen, J. Mulenga, C. A. Derdeyn, S. Allen, E. Hunter, M. Markowitz, P. Hraber, A. S. Perelson, T. Bhattacharya, B. F. Haynes, B. T. Korber, B. H. Hahn, and G. M. Shaw. 2009. Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection. J. Exp. Med. 206:1273-1289.
45. Shattock, R. J., and J. P. Moore. 2003. Inhibiting sexual transmission of HIV-1 infection. Nat. Rev. Microbiol. 1:25-34.
46. UNAIDS. 2008. Report on the global AIDS epidemic. UNAIDS, Geneva, Switzerland.
47. Wolfs, T. F., G. Zwart, M. Bakker, and J. Goudsmit. 1992. HIV-1 genomic RNA diversification following sexual and parenteral virus transmission. Virology 189:103-110.
48. Wolinsky, S. M., C. M. Wike, B. T. Korber, C. Hutto, W. P. Parks, L. L. Rosenblum, K. J. Kunstman, M. R. Furtado, and J. L. Munoz. 1992. Selective transmission of human immunodeficiency virus type-1 variants from mothers to infants. Science 255:1134-1137.
49. Zhu, T., H. Mo, N. Wang, D. S. Nam, Y. Cao, R. A. Koup, and D. D. Ho. 1993. Genotypic and phenotypic characterization of HIV-1 patients with primary infection. Science 261:1179-1181.